RNVA - Rennova Health Fri 13'th Jan 2017
Stock analysis for Fri 13'th Jan 2017 (Updated daily)
Sell candidate since 2017-01-12
Rennova Health Stock Analysis
No changes to the price of Rennova Health in the last trading day. The price has been going up and down for this period, and there has been a 25% gain for the last 2 weeks.
Rennova Health lays the upper part of a very wide and strong falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at USD 0.11 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -38.3% during the next 3 months and, with 90% probability will hold a price between USD 0.02 and USD 0.07 at the end of this period.
There are few to none technical positive signals at the moment. A sales signal was issued from a pivot top point on Wednesday January 11, 2017, which indicates further falls until a new bottom pivot has been found. Volume fell during the last trading day while price remained unchanged. This may be an early warning, but it may also not. We still recommend that you pay attention for the next couple of days.
Relative Strength Index (RSI)
RSI14 is 56 and the stock is currently not being overbought or oversold
Support & Resistance
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days. On the upside the stock meets some resistance from accumulated volume at USD 0.11, USD 0.12.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved USD 0.02 between high and low, or 26.44%. For the last week, the stock has had a daily average volatility of 31.43%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Rennova Health holds several negative signals and is within a very wide and strong falling trend, so we believe it will still perform weak in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.